PanamaTimes

Friday, Jun 13, 2025

Proposal is being prepared to use hydroxychloroquine again against COVID-19

Proposal is being prepared to use hydroxychloroquine again against COVID-19

A group of infectious disease doctors in the front line of battle against Covid-19 signed a proposal for hydroxychloroquine and azithromycin to become part of the drugs for patients with the virus at an early stage.

The doctors argue that recently published data shows that the early use of hydroxychloroquine and azithromycin to treat the disease is associated, clinically and statistically, with the reduction of mortality and admissions in critical care rooms.

The proposal was presented to the dean of the Faculty of Medicine of the University of Panama, Enrique Mendoza, to be discussed in the Advisory Health Council, and with advisers.

Hydroxychloroquine use sparks medical debate

The use of hydroxychloroquine and azithromycin is again a matter of debate among the country's medical community, after Guy De la Rosa, a Panamanian infectologist based in Boston, United States, developed a proposal to resume its use.

The proposal, which was signed by several infectologists from two of the main hospitals in Panama - the Dr. Arnulfo Arias Madrid Hospital Complex and Santo Tomás - recognizes that the therapeutic role of hydroxychloroquine is controversial, but warns that “most of the studies published to date do not reflect the optimal use of the drug, particularly during the early phase of Covid-19 ” .

Doctors argue that recently published data supports the use of hydroxychloroquine for its effect on the "reduction" of days of hospitalization, admission to intensive care units and mortality of patients with the disease.

When speaking of recent data, they refer to a study by the Henry Ford Health System, in southeastern Michigan, in the United States, carried out with a sample of 2,541 hospitalized patients. The study found that those who received hydroxychloroquine were less likely to die. It is detailed that 26% of those who did not receive hydroxychloroquine died, compared to 13% of those who received the drug.

Overall crude mortality rates were 18.1% across the cohort, 13.5% in the hydroxychloroquine alone group, 20.1% among those receiving hydroxychloroquine plus azithromycin, 22.4% among the azithromycin alone group, and 26.4% for none of the medications, the team wrote in a report published in the International Journal of Infectious Diseases.

The infectologists who sign the proposal for the reimbursement of hydroxychloroquine and azithromycin are Alfredo Cantón, Rafael González, Boris Castillo, Darío Flores and Eira García, who provide services at the Dr. Arnulfo Arias Madrid Hospital Complex of the Caja de Seguro Social y the Santo Tomás Hospital.

The proposal was sent this week to the dean of the Faculty of Medicine of the University of Panama, Enrique Mendoza, to be submitted for discussion in the Advisory Health Council, of which he is a member, together with the team of technical advisers of the Minsa.

The issue of the drug was addressed last Sunday, July 5, at the conference "Comprehensive Management of Patients with Covid-19 in phase 1", organized by the Student Association of the Faculty of Medicine of the University of Panama, in In which several doctors from the first line of care participated, who raised their observations on hydroxychloroquine, before its use was suspended, on May 26. Among those panelists were the infectologists who presented the proposal: De la Rosa and Flores.

In that virtual conference, the former Health Minister and member of the Advisory Council, Camilo Alleyne, stated that he would propose a revision to the treatment protocols for patients with Covid-19.

The infectologists agree that the recently published data shows that the early use of hydroxychloroquine and azithromycin for the treatment of the disease is associated, clinically and statistically, with the reduction of mortality, as well as the reduction of admission in the intensive care units. In addition, that the clinical experience regarding the use of hydroxychlorquine and azithromycin for the treatment of Covid-19 in adults in Panama is extensive and supports the effectiveness, as well as the safety, of said drug.

Another approach

Javier Nieto, member of the thematic group protocol and treatment of Covid-19, prepared a proposal that was delivered to the Minister of Health, Eyra Ruíz, in which she states that the evidence, to date, regarding chloroquine and hydroxychloroquine remains debatable and inconclusive given the limitation of the study methodological designs.

It also indicates that there are a not inconsiderable number of regulatory agencies, such as the United States Food and Drug Administration (FDA) and the European Medicines Agency, that have considered discontinuing the use of hydroxychloroquine and the chloroquine as part of patient management with Covid-19, especially since the potential risks from its use may outweigh the benefits.

Nieto recalled that the World Health Organization and Recovery, in the United Kingdom, considered withdrawing the therapeutic arm of hydroxychloroquine given the little benefit of these drugs.

He added that the potential use of this drug could be considered in clinical trials that could evaluate the safety profile and its efficacy, although in the current scenario of withdrawal from the main multicenter trials, this recommendation could be considered a bit out of time.
Newsletter

Related Articles

PanamaTimes
0:00
0:00
Close
UK and EU Reach Agreement on Gibraltar's Schengen Integration
Israeli Finance Minister Imposes Banking Penalties on Palestinians
U.S. Inflation Rises to 2.4% in May Amid Trade Tensions
Trump's Policies Prompt Decline in Chinese Student Enrollment in U.S.
Global Oceans Near Record Temperatures as CO₂ Levels Climb
Trump Announces U.S.-China Trade Deal Covering Rare Earths
Smuggled U.S. Fuel Funds Mexican Cartels Amid Crackdown
Protests Erupt in Los Angeles with Symbolic Flag Burning
Trump Administration Issues New Travel Ban Targeting 12 Countries
Man Group Mandates Full-Time Office Return for Quantitative Analysts
JPMorgan Warns Analysts Against Accepting Future-Dated Job Offers
Builder.ai Faces Legal Scrutiny Amid Financial Misreporting Allegations
Japan Grapples with Rice Shortage Amid Soaring Prices
Goldman Sachs Reduces Risk Exposure Amid Market Volatility
HSBC Chairman Mark Tucker to Return to AIA as Non-Executive Chair
Israel Confirms Arming Gaza Clan to Counter Hamas Influence
Judge Blocks Trump's Ban on International Students at Harvard
Trump Proposes Travel Ban on 'Uncontrolled' Countries
Panama Port Owner Balances US-China Pressures
Trump Administration Accused of Obstructing Deportation Cases
Trump’s China Strategy Remains a Geopolitical Puzzle
Eurozone Inflation Falls Below ECB Target to 1.9%
Call for a New Chapter in Globalisation Emerges
Blackstone and Rivals Diverge on Private Equity Strategy
Mayor’s Security Officer Implicated | Shocking New Details Emerge in NYC Kidnapping Case
Bangkok Ranked World's Top City for Remote Work in 2025
Denmark Increases Retirement Age to 70, Setting a European Precedent
Netanyahu Accuses Western Leaders of 'Emboldening Hamas'
Escalating Trade Tensions and Market Reactions
OnlyFans Reportedly in Talks for $8 Billion Sale
JBS Gains Shareholder Approval for U.S. Stock Listing
Booz Allen Hamilton to Cut 2,500 Jobs Amid Federal Spending Reductions
Trump Signs Executive Orders to Accelerate Nuclear Energy Development
Harvard Temporarily Blocks Trump Administration's International Student Ban
Nippon Steel Forms Partnership with U.S. Steel, Headquarters to Remain in Pittsburgh
Trump Expands Tariff Threats to Apple and Samsung Devices
Oracle and OpenAI Plan $40 Billion Nvidia Chip Purchase for AI Data Center
Trump Threatens 50% Tariff on EU Goods, Markets React
The Daily Debate: The Fall of the Dollar — Strategic Reset or Economic Self-Destruction?
Former FBI Director James Comey Questioned by Secret Service Over Social Media Post
Mexican Influencer Valeria Márquez Killed During Livestream in Suspected Femicide
CIA Files Reveal Klaus Barbie's Role in Bolivian Drug Trade and Dictatorship Support
Daughter of crypto boss escapes Paris kidnap in latest in series of attacks
Why Saudi Arabia Rolled Out a Purple Carpet for Donald Trump Instead of Red
Quantum Computing Threatens Bitcoin Security
Historic Papal Conclave Set to Commence in Rome
Huge Copper, Gold, and Silver Discovery in Argentina and Chile — But the Profits Go Abroad
Trump Rules Out Third Term, Names JD Vance and Marco Rubio as Potential Successors
Mexico Says ‘No’ to U.S. Troops: President Sheinbaum Rejects Trump’s Offer to Fight Cartels
Trump Shares AI-Generated Image of Himself as… Pope, Prompting Outrage Reaction
×